UBA52 Antibody (OTI4E1) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-74729UV
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
Western Blot
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI4E1
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant protein fragment corresponding to amino acids 77-128 of human UBA52 (NP_003324) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for UBA52 Antibody (OTI4E1) [DyLight 350]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: UBA52
Alternate Names
CEP52ubiquitin carboxyl extension protein 52, HUBCEP52, MGC126879, MGC126881, MGC57125, RPL40, UBCEP2, ubiquitin A-52 residue ribosomal protein fusion product 160S ribosomal protein L40, ubiquitin-52 amino acid fusion protein, ubiquitin-60S ribosomal protein L40, ubiquitin-CEP52
Gene Symbol
UBA52
Additional UBA52 Products
Product Documents for UBA52 Antibody (OTI4E1) [DyLight 350]
Product Specific Notices for UBA52 Antibody (OTI4E1) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...